The drug did not significantly improve overall survival or progression free survival in the first-line setting
News
NHS rolls out new online support for diabetes management
The tools are designed to help people manage their condition during the coronavirus pandemic
Just 13 days left to enter Patient Partnership Index
Less than two weeks remain for UK pharma and biotech companies to enter the Patient Partnership Index 2020
NHS waiting lists could hit 10m by year end
The NHS Confederation also warns that ‘it will not be possible to simply ‘switch on’ NHS services immediately’
Final NHS green light for Roche’s Kadcyla
The drug will be funded as an option for treating patients with HER2-positive early breast cancer
EU expands reach of Vertex’ CF drug Kalydeco
Kalydeco is the only approved medicine in Europe to treat the underlying cause of cystic fibrosis in patients with the R117H mutation
Soleno’s drug misses key goal in Prader-Willi trial
The study failed to meet statistical significance for the primary endpoint, however, it did show a number of other significant benefits
Sanofi hands back rights to Oxford Biomedica gene therapies
The move follows a portfolio review by the French drug giant
Kawasaki-like syndrome linked to coronavirus is new condition
The new condition is called Paediatric Inflammatory Multisystem Syndrome Temporally associated with SARS-CoV-2 (PIMS-TS)
NICE rejects Sanofi’s Sarclisa in preliminary guidelines
It is not certain how much more clinical benefit Sarclisa has over existing therapies, the Institute said
EU lockdowns saved more than 3m lives, research indicates
The research also suggests that coronavirus was more infectious than previously estimated
Remdesivir for COVID-19 patients is ‘favourable’, study finds
However, the amount of safety data available for the drug is still limited
Oxford Biomedica and VMIC announce collaboration
The five-year deal will see the parties work collaboratively to facilitate the manufacture of viral vector based vaccines
NHS patients given devices and apps for remote monitoring
The move is part of the NHS drive to give more people connected, personalised care in their own homes
AZ’ Calquence shows promise for COVID-19
Improved markers of inflammation and reduced oxygen requirements were seen in most patients
